LOGIN
.gif)
Efficacy of a cannabis-based oromucosal spray in managing pain of rheumatoid arthritis
October 2018
Efficacy of a cannabis-based oromucosal spray in managing pain of rheumatoid arthritis
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
Rheumatology (Oxford, England). 2006;(1):Feb-50.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
58 patients diagnosed with rheumatoid arthritis (RA) were randomized to either Sativex or placebo. Patients were assessed over 5 weeks of treatment. Significant improvements in pain and quality of sleep were found in patients that received Sativex compared to those that received placebo. No effect was found on morning stiffness. No patients in Sativex group versus two patients in the placebo group...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.